Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/08/2012US20120059061 Novel anti-inflammatory compounds
03/08/2012US20120059060 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
03/08/2012US20120059059 Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid
03/08/2012US20120059058 Dispersions of rasagiline citrate
03/08/2012US20120059057 Antiviral treatments
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120059054 Use Of Copolymers Based On Amino-Containing Polymers As Matrix Binders In Preparing Active Compound-Containing Granules And Administration Forms
03/08/2012US20120059053 Compounds of 2,3-dihydro-benzofuran
03/08/2012US20120059052 Prenylflavonoid formulations
03/08/2012US20120059050 Garcinia derivative, its preparing method and medicinal use
03/08/2012US20120059049 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/08/2012US20120059048 METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
03/08/2012US20120059047 Differentiation modulating agents and uses therefor
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059045 Methods of using oligomeric compounds comprising 2'-substituted nucleosides
03/08/2012US20120059044 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
03/08/2012US20120059043 Therapeutic and diagnostic strategies
03/08/2012US20120059042 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
03/08/2012US20120059041 Methods for Extending Lifespan in Subject
03/08/2012US20120059040 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
03/08/2012US20120059039 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
03/08/2012US20120059038 Polyketide compound
03/08/2012US20120059037 Substituted pyridine derivatives and their medical use
03/08/2012US20120059036 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
03/08/2012US20120059035 Method of predicting a predisposition to qt prolongation
03/08/2012US20120059034 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
03/08/2012US20120059033 Crystalline Salts of a Potent HCV Inhibitor
03/08/2012US20120059032 1,2,3,4-tetrahydroisoquinoline derivatives effective as antiglioma agents, methods of making, and their use
03/08/2012US20120059031 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/08/2012US20120059030 Heterocyclic compound and use thereof
03/08/2012US20120059029 Selective integrin inhibitors
03/08/2012US20120059028 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
03/08/2012US20120059027 Tacrolimus injection preparation
03/08/2012US20120059026 Antimicrobial agents
03/08/2012US20120059025 Dry powder compound formulations and uses thereof
03/08/2012US20120059024 Drug abuse deterrent, methods and compositions
03/08/2012US20120059023 Use of polymorphic forms of rifaximin for medical preparations
03/08/2012US20120059022 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoicacid] Calcium Salt
03/08/2012US20120059021 Compositions and methods for treating cancer and methods for predicting a response to such treatments
03/08/2012US20120059020 Prophylactic or therapeutic agent for pulmonary fibrosis
03/08/2012US20120059019 Compounds for the Treatment of Hepatitis C
03/08/2012US20120059018 Novel chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same
03/08/2012US20120059017 CGRP Receptor Antagonist
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059015 Novel spiroheterocyclic compounds as mglu5 antagonists
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059013 Method of treating early morning akinesia in subjects having parkinson's disease
03/08/2012US20120059012 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/08/2012US20120059011 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
03/08/2012US20120059010 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/08/2012US20120059009 Anti-tumor agent containing tegafur-gimeracil-oteracil potassium combination drug and oxaliplatin
03/08/2012US20120059008 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
03/08/2012US20120059007 Pharmacologically-active vanilloid carbamates
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059005 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases
03/08/2012US20120059004 Compounds And Compositions For Treating Cancer
03/08/2012US20120059003 Inhibitors of inv(16) leukemia
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058998 Compounds, Compositions and Methods for the Treatment of Inflammatory Diseases
03/08/2012US20120058997 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
03/08/2012US20120058996 Carbazole carboxamide compounds useful as kinase inhibitors
03/08/2012US20120058995 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
03/08/2012US20120058994 Novel compounds
03/08/2012US20120058993 Stable Suspension Formulation
03/08/2012US20120058992 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis
03/08/2012US20120058991 Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
03/08/2012US20120058990 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
03/08/2012US20120058989 Antibacterial fluoroquinolone analogs
03/08/2012US20120058988 Carbazole and carboline kinase inhibitors
03/08/2012US20120058987 Therapeutic uses of quinazolinedione derivatives
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058983 Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012US20120058982 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058980 Aerosol formulation for the inhalation of beta agonists
03/08/2012US20120058979 Methods and reagents for the treatment of immunoinflammatory disorders
03/08/2012US20120058978 Method for the treatment of central nervous system cancers and compositions related thereto
03/08/2012US20120058977 Pharmaceutical compositions and methods for treating tuberculosis
03/08/2012US20120058976 Phosphonate Ester Derivatives and Methods of Synthesis Thereof
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058973 Compositions comprising a silicone water-in-oil emulsifier and a low nitrogen containing amino-functional silicone gum
03/08/2012US20120058972 Novel use
03/08/2012US20120058971 Cyclodextrin-based polymers for therapeutic delivery
03/08/2012US20120058970 Method and system for reversal of interactions between hydrophobically modified biopolymers and vesicles or cell membranes
03/08/2012US20120058969 Cystitis treatment with high dose chondroitin sulfate
03/08/2012US20120058968 Composition containing fermantable polysaccharides
03/08/2012US20120058967 Vascular protecting agent having salt-absorption inhibitory activity
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058965 Methods and systems for modulating hormones and related methods, agents and compositions
03/08/2012US20120058964 Pharmaceutical formulation
03/08/2012US20120058963 Macrolides with Anti-Inflammatory Activity
03/08/2012US20120058962 Buccal and/or sublingual therapeutic formulation
03/08/2012US20120058961 Pharmaceutical Composition for Treating Cancers
03/08/2012US20120058960 Feedback prodrug
03/08/2012US20120058959 Topical antiviral formulations
1 ... 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 ... 7860